Imagine a world where a diagnosis of gastric cancer no longer carries the weight of a dire prognosis, where innovative treatments offer a real chance at long-term survival even for those in the early stages of this aggressive disease. This vision is inching closer to reality with the recent
A therapy that should unleash the immune system instead fuels a tumor’s growth, and the only way to see why is to listen to each cell speak for itself; that is the everyday paradox that single-cell RNA sequencing (scRNA-seq) now makes decipherable in real time. In oncology, this shift from average
Imagine a world where a lung cancer diagnosis no longer feels like a death sentence, but rather a challenge that can be managed with the right tools and support. For too long, this disease has carried a heavy burden of fear and stigma, often seen as an unstoppable force due to its high mortality
In cancer trials where survival curves dominate headlines yet leave the lived experience in the margins, a new consensus promises to pull patient voices into the center of decision-making by standardizing how those voices are captured, analyzed, and reported. Patient-reported outcomes (PROs) have
Across the human genome, a narrow slice at the very start of genes keeps leaving the same telltale mark—mutations that appear more often than expected and matter more than many once thought, compelling a rethink of how models, pipelines, and clinics treat these small but powerful stretches. Recent
Watching a single enzyme switch from a standstill to full sprint while decoding DNA inside a mammalian cell would have sounded like science fiction not long ago, yet that leap just became a measurable reality thanks to a single-molecule transcription platform that links factor binding to RNA
